
Aptorum Group Limited APM
$ 0.84
0.0%
Annual report 2025
added 04-25-2026
Aptorum Group Limited Total Inventories 2011-2026 | APM
Annual Total Inventories Aptorum Group Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 39.1 K | 34.2 K | 30.6 K | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 39.1 K | 30.6 K | 34.7 K |
Quarterly Total Inventories Aptorum Group Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 35.8 K | - | 32.8 K | - | 39.1 K | - | 34.3 K | - | 34.2 K | - | - | - | 30.6 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 39.1 K | 30.6 K | 34.5 K |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Exelixis
EXEL
|
21.7 M | $ 48.16 | 4.22 % | $ 13.1 B | ||
|
Fortress Biotech
FBIO
|
9.62 M | $ 2.39 | -0.42 % | $ 66.7 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
91.7 M | $ 22.4 | -0.71 % | $ 3.71 B | ||
|
Esperion Therapeutics
ESPR
|
105 M | $ 3.14 | - | $ 653 M | ||
|
Gilead Sciences
GILD
|
1.77 B | $ 131.33 | -2.04 % | $ 163 B | ||
|
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
22.6 M | $ 21.17 | 2.47 % | $ 2.69 B | ||
|
Autolus Therapeutics plc
AUTL
|
33.2 M | $ 1.57 | -2.48 % | $ 418 M |